0000899243-22-003416.txt : 20220127 0000899243-22-003416.hdr.sgml : 20220127 20220127160024 ACCESSION NUMBER: 0000899243-22-003416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220125 FILED AS OF DATE: 20220127 DATE AS OF CHANGE: 20220127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORESHACK KURT CENTRAL INDEX KEY: 0001832579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39725 FILM NUMBER: 22563100 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARAVAI LIFESCIENCES HOLDINGS, INC. CENTRAL INDEX KEY: 0001823239 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 546-0004 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-25 0 0001823239 MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI 0001832579 ORESHACK KURT C/O MARAVAI LIFESCIENCES HOLDINGS, INC. 10770 WATERIDGE CIRCLE, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 General Counsel Class A Common Stock 2021-04-30 5 A 0 E 495 22.95 A 7995 D Class A Common Stock 2021-10-31 5 A 0 E 542 22.95 A 8537 D Class A Common Stock 2022-01-25 4 A 0 17000 A 25537 D Employee Stock Option (Right to Buy) 26.32 2022-01-25 4 A 0 31500 0.00 A 2032-01-25 Class A Common Stock 31500 31500 D The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer. Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. /s/ Kurt Oreshack 2022-01-27